当前位置:
X-MOL 学术
›
Nat. Rev. Urol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Artificial intelligence in the management of prostate cancer
Nature Reviews Urology ( IF 12.1 ) Pub Date : 2024-09-04 , DOI: 10.1038/s41585-024-00938-z Raghav Khanna 1 , Alejandro Granados Martinez 2 , Nicholas Raison 1 , Sebastien Ourselin 2 , Alberto Briganti 3 , Francesco Montorsi 3 , Prokar Dasgupta 1
Nature Reviews Urology ( IF 12.1 ) Pub Date : 2024-09-04 , DOI: 10.1038/s41585-024-00938-z Raghav Khanna 1 , Alejandro Granados Martinez 2 , Nicholas Raison 1 , Sebastien Ourselin 2 , Alberto Briganti 3 , Francesco Montorsi 3 , Prokar Dasgupta 1
Affiliation
Artificial intelligence (AI) is transforming prostate cancer management from diagnosis to treatment. AI tools have been designed for the analysis of digitized histopathology and MRI scans, generation of synthetic CT scans and improvement of robotic surgical outcomes. This progress underscores the need for regulation and the development of safe, ethical and non-biased software.
中文翻译:
人工智能在前列腺癌治疗中的应用
人工智能 (AI) 正在将前列腺癌管理从诊断转变为治疗。人工智能工具旨在分析数字化组织病理学和 MRI 扫描、生成合成 CT 扫描以及改善机器人手术结果。这一进展强调了监管和开发安全、道德和无偏见软件的必要性。
更新日期:2024-09-05
中文翻译:
人工智能在前列腺癌治疗中的应用
人工智能 (AI) 正在将前列腺癌管理从诊断转变为治疗。人工智能工具旨在分析数字化组织病理学和 MRI 扫描、生成合成 CT 扫描以及改善机器人手术结果。这一进展强调了监管和开发安全、道德和无偏见软件的必要性。